Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

NCT00831766 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions

DRUG: Idarubicin
DRUG: Cytarabine
DRUG: Lenalidomide (Revlimid®)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]